Re: E-DRUG: Investigation of Amgen suppression of EPO invention

["Randy Trinkle" <rtrinkle@rosencrantz.citytel.net>]

-------------------------------------------------
E-DRUG: Investigation of Amgen suppression of EPO invention
Sender: owner-e-drug@usa.healthnet.org
Precedence: bulk
Reply-To: e-drug@usa.healthnet.org
Errors-To: owner-e-drug@usa.healthnet.org

In perusing some messages that I'd saved I came
across this (from over a year ago).  Is there
any update?

The gist was a means of reducing the amount of
EPO required for a clinically-effective dose.

***************************************
Randy Trinkle, BScPharm, BA
Pharmacy Department
Prince Rupert Regional Hospital
mailto:rtrinkle@mail.citytel.net
Health Science links:
http://www.rupert.net/~rtrinkle
***************************************

'What's the most important thing in life to you?'

Data.

'No, no--I mean, what makes you happy, satisfied?'

Good data.

[Moderators comment I have heard nothing. I wonder if Jamie Love will be
distracted by testifying before Congress or if he will be able to update us?
Richard Laing]

--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to:  `owner-e-drug@usa.healthnet.org'.